https://pmc.ncbi.nlm.nih.gov/articles/PMC11507497/

In the field of medical devices, the size design of any blood-drawing needle (including various blood collection needles and lancets) is not solely determined by clinical needs or engineering capabilities. It must be designed in compliance with global and regional standards, regulatory frameworks, and risk management requirements. The size parameters are the core content of product registration, quality evaluation, and post-market supervision.

The Size-Related Requirements in International Standards

Although there is no separate product standard named "bleeding needle," its size attributes are included in several general medical device standards.

• ISO 7864: One-time use sterile subcutaneous injection needles: This standard is an important reference for the compliance of blood collection needle sizes. It specifies the tolerance range of the outer diameter and length of the needle tube, as well as the testing methods for the sharpness of the needle tip and the penetration force. Although therapeutic blood collection needles may be thicker, the basic dimensional accuracy and performance requirements of this standard can be followed as a guideline.
• ISO 23908: Sharps with injury prevention devices: For blood collection needles with safety protection devices, this standard stipulates the length of the needle tip retraction or occlusion (i.e., the safety travel size) after the protection device is activated, ensuring that it can effectively prevent accidental needle injuries.
• ISO 11608: Needle for pen-type injectors: For certain therapeutic blood collection operations connected to specific devices, the needle size for these operations must comply with relevant administration equipment standards.
• Dimensions and Biocompatibility (ISO 10993): Although not directly specifying dimensions, the biocompatibility tests of the materials are closely related to the surface area of the product (directly related to the dimensions) and the contact area and duration. A thicker and longer needle means a larger contact area with tissues/blood, and thus more stringent safety requirements for the material are necessary.

Design Inputs within the Regulatory Framework

In the major global markets (China NMPA, USA FDA, EU MDR), the registration and filing requirements for medical devices describe and verify the size as a key product technical characteristic.

• Design Input: The regulations require that manufacturers clearly specify all the dimensional parameters and their clinical basis (why is this diameter? why is this length?). For instance, the insertion depth of the lancet needle must be supported by sufficient biomechanical and safety data to prove that it can effectively draw blood while avoiding injury to deeper structures.
• Risk Management (ISO 14971): Size is an important factor in risk analysis. For example, an overly thick needle diameter may lead to increased risks of tissue damage and pain (requiring a balance of flow requirements); an excessively long needle may result in accidental penetration of deep blood vessels or nerves; insufficient depth of the lancet needle may lead to insufficient blood collection, while excessive depth may increase the risks of pain and injury. Manufacturers must identify, assess, and control these risks related to size.

Verification and Confirmation of Dimensions

Compliance requirements mandate strict control and verification of the dimensions.

• Process Verification: All processes that affect the dimensions during the manufacturing process (such as drawing, cutting, and grinding) must undergo process validation to prove that they can consistently and stably produce products that meet the tolerance requirements.
• Inspection and Testing: The factory inspection must include sampling or full inspection of key dimensions (outer diameter, length, needle tip angle, etc.), using calibrated precision measuring equipment. At the same time, performance tests such as "penetration force test" essentially represent a comprehensive reflection of dimensional accuracy, needle tip sharpness, and material strength, and are mandatory inspection items as required by regulations.

Customized Size Compliance Path

When the manufacturer customizes based on the 2D/3D drawings or samples provided by the customer (hospital or research institution), the compliance responsibility does not transfer. The manufacturer needs to incorporate the customized dimensions as a new design input, re-evaluate their compatibility with existing materials and processes, and conduct necessary design verification and confirmation (including biocompatibility, performance, and safety evaluations) to ensure that the customized product also meets all applicable standards and regulatory requirements.

Conclusion

The size of the blood-drawing needle ranges from millimeters to micrometers. Each digit represents rigorous standards and regulatory requirements. It is not only a parameter on engineering drawings but also a quantitative carrier of the safety and effectiveness of medical devices. Under the ISO 13485 quality management system, size management runs through the entire life cycle from design and development, procurement, production to after-sales feedback. Compliance with size design is the cornerstone for the legal launch of products and gaining market trust. With the increasingly strict and coordinated global medical device regulations, precise control of size data, thorough verification, and transparent reporting have become indispensable core capabilities for all responsible manufacturers. In the future, with the development of personalized medicine, how to efficiently and safely achieve "personalized customization" of sizes within the compliance framework will be a new challenge for the industry.